http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94e7e503646f811dbd97dff4a47b5573
Outgoing Links
Predicate | Object |
---|---|
family-name | Berchuck |
name | Andrew Berchuck |
given-name | Andrew |
organization-name | Department of Obstetrics and Gynecology Duke University Medical Center Durham USA From the Massachusetts General Hospital and Harvard Medical School, Boston, MA; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Duke University Medical Center, Durham, NC; Johns Hopkins Medical Institutions, Baltimore, MD; Groningen University Hospital, Groningen, the Netherlands; and St Bartholomew’s Hospital, London, United Kingdom 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; Department of Obstetrics and Gynecology Duke University Durham NC 9Duke University Medical Center, Durham, North Carolina Duke Cancer Institute Duke University Medical Center Durham North Carolina USA Division of Gynecologic Oncology, Duke University School of Medicine, Durham, NC, USA. 6Department of Gynecologic Oncology, Duke University School of Medicine, Durham, North Carolina. 33Department of Gynecology, Duke University Medical Center, Durham, North Carolina. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology Duke University Medical Center Durham NC Department of Obstetrics and Gynecology Duke University Medical Center Durham NC Department of Obstetrics and Gynecology Duke University Medical Center Durham North Carolina United States of America 1Comprehensive Cancer Center, Departments of; 22Cancer Research UK Genetic Epidemiology Unit and; 3Obstetrics and Gynecology, and; 22Cancer Research UK Genetic Epidemiology Unit and; 28The Ovarian Cancer Association Consortium, Durham, North Carolina; 22Cancer Research UK Genetic Epidemiology Unit and Departments of Obstetrics and Gynecology, North Chicago, Illinois Andrew Berchuck, Laura J. Havrilesky, and Noah D. Kauff, Duke University Medical Center, Durham, NC Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, United States of America. 1Obstetrics and Gynecology/Division of Gynecologic Oncology, Departments of Duke Cancer Institute, Duke University Medical Center, Durham, NC Department of Gynecologic Oncology, Duke University Medical Center, Durham, NC 277170, USA. Electronic address: [email protected]. 7Duke Cancer Institute; 1Division of Gynecologic Oncology/Department of Obstetrics and Gynecology and; 3Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina; Departments of Obstetrics and Gynecology/Division of Gynecologic Oncology, Pathology, Community and Family Medicine, and Surgery, Duke University Medical Center, Durham, North Carolina; Division of Gynecologic Oncology, Duke University Medical Center, Box 3079, Durham NC 27710; 11Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. 13Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina. Department of Obstetrics and Gynecology, Duke University Medical Center, 3079, Durham, NC 27710, USA. Authors' Affiliations: 1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Roche Department of Obstetrics and Gynecology, 1Department of Obstetrics and Gynecology/Division of Gynecologic Oncology,; 2Institute for Genome Sciences and Policy, Departments of 6Duke Cancer Institute; Division of Gynecologic Oncology, Duke Cancer Institute, Duke University School of Medicine , Durham, NC, USA Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC Departments of Obstetrics and Gynecology, Division of Gynecologic Oncology, Genetics, and Surgery, Duke University Medical Center, Durham, North Carolina, and Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina Duke Cancer Institute, Division of Gynecologic Oncology, Duke University School of Medicine, Durham, North Carolina 5Duke Comprehensive Cancer Center,; 6Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, and; 7Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina Authors' Affiliations: 1Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; 2Department of Health Sciences Research and 3Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 4The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Brisbane, Australia; 5Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia; 6Center for Cancer Research, National Cancer Institute, NIH, Gaithersburg, Maryland; 7Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; 10German Cancer Research Center (DKFZ), Heidelberg, Germany; 11Division of Cancer Genetics and Epidemiology, National Cancer Institute, NIH, Rockville, Maryland; 12Department of Obstetrics and Gynaecology, Univ Division of Gynecologic Oncology Department of Obstetrics and Gynecology Duke University Medical Center Durham North Carolina; Duke Cancer Institute Duke University Medical Center Durham North Carolina Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University, Durham, NC 27710, USA Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. Department of Obstetrics and Gynecology Duke University Medical Center Durham North Carolina Department of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA. Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina Authors' Affiliations: 1Department of Health Sciences Research, Division of Epidemiology; 2Department of Medical Oncology; 3Department of Health Sciences Research, Division of Biomedical Statistics and Informatics; 4Department of Laboratory Medicine and Pathology, Division of Experimental Pathology; 5Department of Immunology; 6Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota; 7Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; 8Department of Epidemiology and Biostatistics; 9Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York; 10Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas; 11Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center; 12Women's Cancer Program, 13Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; 14Department of Medicine, Division of Hematology and Onco 127Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. Department of Obstetrics and GynecologyDuke University Medical CenterDurham NC Duke University Medical Center, Durham, North Carolina Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA Authors' Affiliations: Departments of 1Community and Family Medicine, 2Statistical Science, 3Obstetrics and Gynecology, Division of Gynecologic Oncology, 4Pathology, and 5Surgery, 6Duke Cancer Institute, and 7Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina; Authors' Affiliations: Departments of 1Community and Family Medicine, 2Statistical Science, 3Obstetrics and Gynecology, Division of Gynecologic Oncology, 4Pathology, and 5Surgery, 6Duke Cancer Institute, and 7Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina; Authors' Affiliations: Departments of 1Community and Family Medicine, 2Statistical Science, 3Obstetrics and Gynecology, Division of Gynecologic Oncology, 4Pathology, and 5Surgery, 6Duke Cancer Institute, and 7Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina Authors' Affiliations: Departments of 1Poultry Science and 2Population Health and Pathobiology, N.C. State University, Raleigh; 3Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina; and 4Division of Gynecologic Oncology, NorthShore University Health System, University of Chicago, Chicago, Illinois Department of Gynecologic Oncology, Duke University Hospital , Durham, NC, USA 4Department of Obstetrics and Gynecology/Division of Gynecologic Oncology and the Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: [email protected]. Division of Gynecologic Oncology Duke University Medical Center Durham North Carolina 2Division of Gynecologic Oncology, Duke University School of Medicine, Durham, North Carolina. 8Duke University Medical Center, Durham, North Carolina Authors' Affiliations: 1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; 2Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA; 3Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; 4Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA; 5Department of Oncology, University of Cambridge, Cambridge, UK; 6Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; 7Cancer Division, Queensland Institute of Medical Research, Herston, QLD, Australia; 8Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 9Department of Epidemiology, University of Washington, Seattle, WA, USA; 10Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; 11Department of Epidemiology, Harvard School of Public Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA 4Department of Obstetrics/Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina. Society of Gynecologic Oncologists; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 15Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. Authors' Affiliations: 1Department of Gynecologic Oncology, City of Hope, California; 2Department of Assay Research and Development, Abbott Molecular, Des Plaines, Illinois; 3College of Veterinary Medicine and 4Department of Poultry Science, North Carolina State University, Raleigh, North Carolina; 5Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina; 6Moffitt Cancer Center, University of South Florida, Tampa, Florida; and 7Chemoprevention Branch, National Cancer Institute, Bethesda, Maryland Department of Obstetrics and Gynecology Duke University Medical Center Durham NC USA Andrew Berchuck, Angeles Alvarez Secord, Haley A. Moss, and Laura J. Havrilesky, Duke University Medical Center, Durham, NC Division of Gynecologic Oncology Department of Obstetrics and Gynecology Duke University Medical Center Durham North Carolina; Duke Cancer Institute, Duke University Medical Center Durham North Carolina Authors' Affiliations: 1Biostatistics Center; 2Gynecologic Oncology; 3Clinical Pathology Core Laboratories, Massachusetts General Hospital, Boston, Massachusetts; 4Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics; 5Epidemiology and Genetics Research Program, Division of Cancer Control and Prevention Sciences, National Cancer Institute; 6Office of the Director, Eunice Kennedy Shriver National Institute for Child Health & Human Development, Bethesda, Maryland; 7GOG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York; 8Department of Gynecology, Swedish Medical Center, Seattle, Washington; 9Department of Medicine and Oncology, Lombardi Comprehensive Center, Georgetown University, Washington, District of Columbia; 10Oncology, Gynecology and Obstetrics, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland; 11Hematology and Oncology, Huntsman Cancer Institute, Salt Lake City, Utah; 12NorthShore University Health System, Evanston, Northwestern Healthcare, Evanston, Authors' Affiliations: 1Department of Epidemiology and Public Health, Yale University School of Public Health, School of Medicine, New Haven, Connecticut; 2Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; and 3Department of Oncology, University of Cambridge, Cambridge, United Kingdom Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. From the Divisions of Gynecologic Surgical Oncology and Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Institute for Genome Sciences and Policy, Department of Molecular Genetics and Microbiology, Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, and Departments of Surgery and Medicine, Duke University Medical Center; Institute of Statistics and Decision Sciences, Duke University, Durham, NC; and Institute of Medical Genetics,... 2Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina. Duke University Medical Center, Duke Cancer Institute, Durham, North Carolina 27710, USA. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology Duke University Medical Center Durham NC USA Division of Gynecologic Oncology, Duke University School of Medicine, Durham, North Carolina. Department of Obstetrics and Gynecology Division of Gynecologic Oncology Duke University Medical Center Durham North Carolina USA Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA. Authors' Affiliations: 1Curriculum in Applied Science and Engineering, 2Department of Physics and Astronomy, UNC-Chapel Hill, Chapel Hill; Departments of 3Department of Medicine and Pharmacology and Cancer Biology and 4Gynecology and Obstetrics, Duke University Medical Center, Durham, North Carolina Authors' Affiliations: 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; 2Department of Biostatistics & Bioinformatics; 3Cancer Center Biostatistics, Duke University Medical Center, Durham, North Carolina; and 4Division of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida 18Gynecologic Cancer Program, Duke Cancer Institute, Durham, North Carolina. Division of Gynecologic Oncology, Duke University School of Medicine , Durham, NC, USA Authors' Affiliations: 1Department of Women's Oncology, 2Experimental Therapeutics Program, 3Biostatistics Core, 4Bioinformatics Core, 5Department of Anatomic Pathology, and 6Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute; 7James A. Haley Veterans' Hospital, Tampa, Florida; 8College of Life Information Sciences and Instrument Engineering, Hangzhou Dianzi University; 9Zhejiang Cancer Hospital, Hangzhou, China; and 10Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University, Durham, North Carolina 16Duke University Medical Center, Durham, North Carolina; 15Duke University Medical Center, Division of Gynecologic Oncology, Durham, North Carolina. 4Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center , Durham, NC, USA From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cancer Prevention, Detection, and Control Research Program, Duke University Medical Center, Durham, NC Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA. [email protected] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC 3Division of Gynecologic Oncology, Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina; 164Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. Department of Obstetrics and Gynecology, Duke University , Durham, NC , USA 6Division of Gynecologic Oncology, Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina. 3Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University, Durham, North Carolina 19Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; 4Duke University Medical Center, Durham, North Carolina; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 3Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University, Durham, North Carolina 2Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina. Departments of Obstetrics and Gynecology, Pathology, and Surgery, Duke Umnversity Medical Center, Durham, North Carolina; Duke University Medical Center, Division of Gynecologic Oncology, Box 3079, Durham, NC 27710 69Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina. Authors' Affiliations: 1Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 2Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California; 3School of Public Health, The University of Texas, Houston, Texas; 4Roswell Park Cancer Institute, Buffalo, New York; 5The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 7Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany; 8Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 9Department of Viruses, Hormones, and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society; 10The Juliane Marie Centre, Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark; 11Mayo Clinic College of Medicine, Rochester, Minnesota; 12Obstetrics and Gynecology, and 13Community and Family Medicine, Duke Univ Department of Obstetrics and Gynecology; Duke University Medical Center; Durham NC 4Duke University Medical Center, Durham, North Carolina Department of Obstelrics and Gyncology Division of Gyncologic Oncology, Duke University Medical Center, Durham, North Carolina.; Department of Medicine, Duke University Medical Center, Durham, North Carolina. Department of Obstetrics and Gynecology and Duke Cancer Institute, Duke University School of Medicine . Durham, North Carolina , USA 1Division of Gynecologic Oncology,; 2Duke Institute for Genome Sciences and Policy, and Departments of Obstetrics and Gynecology/Division of Gynecologic Oncology, Surgery, and Genetics, Duke University Medical Center, Durham, North Carolina; Duke University Medical Center, Box 3079, Durham, NC 27710 Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA Division of Gynecologic Cuke University Medical Center, Durham, North Carolina; Authors' Affiliations: Departments of 1Health Sciences Research, Division of Epidemiology, 2Medical Oncology, 3Health Sciences Research, Division of Biomedical Statistics and Informatics, 4Immunology, and 5Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota; 6Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida; 7Channing Division of Network Medicine, 8Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School; 9Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 10Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut; 11Department of Clinical Science, University of Bergen; Departments of 12Gynecology and Obstetrics, and 13Pathology, Haukeland University Hospital, Bergen, Norway; Departments for 14Health Evidence, 15Urology, and 16Gynaecology, Radboud University Medical Centre, Nijmegen; 17 Duke University Medical Center, Room 25172, Durham, NC 27710, USA. Electronic address: [email protected]. |
Incoming Links
Showing number of triples: 1 to 618 of 618.